Tag: Big Pharma
âIn a Tight Race, Pharmaâs Favorite Senator gets a Little help...
STAT reports that Senator Richard Burr, who has consistently protected the pharmaceutical and biotech industries from regulation, is getting a boost in funding from...
âReadying for Pricing Fight, Drug Lobby to add $100 Million to...
STAT reports that the drug industryâs top lobbying group is attempting to boost its funds in anticipation of a show down with regulators. Clinton...
âSanders Seeks Ariad Data on Cancer Drug Price Hikesâ
For STAT, Ed Silverman reports on the former presidential candidate Bernie Sanders' ongoing fight against pharmaceutical companies. Sanders sent Ariad Pharmaceuticals  a letter asking for...
âDriven to Suicide by an âInhuman and Unnaturalâ Pressure to Sellâ
Todayâs New York Times features a story of a drug salesman, Ashish Awasthi, who committed suicide when he felt he couldnât keep up with...
âSelling Side Effects: Big Pharmaâs Marketing Machine?â
Drug Watch releases an in-depth investigation into the marketing practices of pharmaceutical companies in the United States. âCompanies spend billions advertising to doctors to...
Mental Health Treatments Top List of US Healthcare Spending
According to new research, the United States spends over 200 billion annually on treatment and hospitalization for mental health issues, exceeding spending on heart...
âHow Big Pharma Uses Charity Programs to Cover for Drug Price...
Bloomberg Businessweek reports that âU.S. taxpayers support a billion-dollar system in which charitable giving is, in effect, a very profitable form of investing for...
âHarvard Affiliates Protest at Tufts for âPharma Fools Dayââ
Students from Harvard Medical School joined students from Tufts University to protest Joseph DiMasi, who recently published a study that the students claim is...
âPfizer Abandons $160bn Allergan Dealâ
After the US announced plans to crack down on âinversion deals,â where a US company merges with a foreign company to escape taxes, Pfizer...
âBig Pharma Settlements Highlight the Need for Tougher Enforcementâ
âStronger enforcement is needed to deter pharmaceutical manufacturers from continuing to break the law and defraud federal and state health programs, according to a...
âLook Beyond Martin Shkreli for Pharma Reformâ
Martin Shkreli, the former hedge fund manager who became infamous for buying a life-saving drug and then raising the price significantly, was led away in handcuffs by the FBI last week. Unfortunately, the Boston Globe editorial board reminds us, âviewing his much-publicized takedown as anything like a tipping point in the push for pharmaceutical industry reform would be a mistake.â
âThe Rise and Fall of the Blockbuster Antipsychotic Seroquelâ
Martha Rosenberg highlights how the popular antipsychotic Seroquel is a perfect example of how direct-to-consumer advertising made billion dollar blockbuster drugs possible before side-effects...
âBernie Sanders Blasts FDA Commish Nominee Califfâ
Democratic Presidential nominee, Bernie Sanders, questioned the nominee for FDA commissioner, Robert Califf, during yesterdayâs Senate hearing. Sanders remarked that we need a commissioner who will stand up to the pharmaceutical companies and protect American consumers. Of Califf, he added, âwith regret, I think that you are not that person.â
Study 329: Big Risk
Study 329 seems to fit the classic picture: It has Big Pharma ghostwriting articles, hiding data, corrupting the scientific process and leaving a trail of death, disability and grieving relatives in its wake. But is it at fault alone? Both Big Pharma and Big Risk (the insurance industry) were once our allies in keeping our hopes alive â in keeping our children alive and well. They are now a threat. And of the two â Big Risk is the bigger threat.
âPsychotic Shooters on the Open Frontier of Profitâ
At CounterPunch, Joseph Natoli connects Big Pharma, mass shootings, and rampant inequality. He writes: âThe Brave New World soma strategy to deal with a population that, were they not doped up, might violently disrupt that brave new world, is useful if a society is âcreatively destroyingâ a growing number of its population each day. While the poor have daily evidence of their poverty, a collapsing middle class live in the illusion that they are middle class and just a short distance, not from ruin, but from fame and fortune. They are, in short, heading for a catastrophic break-down. Big Pharma is already set to give us all a âsoft landing.ââ
Massive Number of Antidepressant Meta-Analyses Biased By Industry
A massive number of meta-analyses of antidepressant clinical trials have financial conflicts of interest and are unduly influenced by pharmaceutical companies, according to a review to be published in an upcoming issue of the Journal of Clinical Epidemiology. Researchers also found that meta-analyses with industry ties almost never report any negative findings in their abstracts.
Bernie Sanders Opposes Califf for FDA Post Cites Industry Ties
Bernie Sanders joins numerous public health groups and opposes Robert Califf's nomination to lead the FDA over industry ties.
âHolding Big Pharma Accountable: Why Suing the Pharmaceutical Industry Isn’t Workingâ
Writing for the Huffington Post, Caroline Beaton looks into how drugs continue to make billions in sales even after they lose lawsuits for fraud and misconduct. âThe persistence of Big Pharma's fraud despite ubiquitous legal action suggests that our present efforts to hold the industry accountable are ineffective,â Beaton writes. âNew polices in motion will make potentially unsafe drugs even easier to bring to market and promote.â
Can Its New Board President Turn NAMI Around?
âThe word is out!â That was Dr. Keris Myrickâs reaction when she was elected earlier this month as the new president of NAMIâs Board...